Allspring Global Investments
SRPT icon

Allspring Global Investments’s Sarepta Therapeutics SRPT Stock Holding History

Allspring Global Investments’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-50,463
Closed -$894K – 1720
2025
Q2 		$894K Sell
50,463
-9
-0% -$384 ﹤0.01% 1193
2025
Q1 		$3.12M Sell
50,472
-34,962
-41% -$3.68M 0.01% 1015
2024
Q4 		$10.6M Buy
85,434
+84,926
+16,718% +$10.4M 0.02% 741
2024
Q3 		$63.5K Sell
508
-21,269
-98% -$2.94M ﹤0.01% 1827
2024
Q2 		$3.44M Sell
21,777
-239,511
-92% -$30.8M 0.01% 1034
2024
Q1 		$33.8M Sell
261,288
-12,373
-5% -$1.52M 0.05% 431
2023
Q4 		$26.4M Sell
273,661
-80,841
-23% -$7.75M 0.04% 488
2023
Q3 		$43M Sell
354,502
-188,410
-35% -$21.3M 0.08% 340
2023
Q2 		$62.2M Buy
542,912
+4,475
+0.8% +$577K 0.1% 255
2023
Q1 		$74.2M Buy
538,437
+161,184
+43% +$20.9M 0.12% 211
2022
Q4 		$48.9M Buy
377,253
+112,579
+43% +$13M 0.08% 327
2022
Q3 		$29.3M Buy
264,674
+55,306
+26% +$5.57M 0.05% 460
2022
Q2 		$15.7M Sell
209,368
-4,704
-2% -$346K 0.03% 657
2022
Q1 		$16.7M Buy
+214,072
New +$16.4M 0.02% 718

Other funds holding SRPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Allspring Global Investments's SRPT Position: Q3 2025 in Review

Allspring Global Investments sold out of Sarepta Therapeutics (SRPT) in Q3 2025, closing a stake of 50,463 shares — an estimated $894K sold.

Allspring Global Investments first reported a position in SRPT in Q1 2022 and held it in 14 quarters. The position peaked at $74.2M in Q1 2023. 319 funds tracked by Wall St. Rank hold SRPT as of Q3 2025.

  • Allspring Global Investments reported no remaining Sarepta Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Allspring Global Investments sold 50,463 Sarepta Therapeutics shares in Q3 2025, an estimated $894K.
  • Allspring Global Investments first reported a position in Sarepta Therapeutics in Q1 2022 and held it in 14 quarters.
  • Allspring Global Investments's Sarepta Therapeutics position peaked at $74.2M in Q1 2023.
  • 319 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q3 2025.

Based on Allspring Global Investments's 13F filing for Q3 2025, filed 20 Oct 2025.